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Acknowledging separable factors underlying negative symptoms may lead to better
understanding and treatment of negative symptoms in individuals with schizophrenia.
The current study aimed to test whether the negative symptoms factor (NSF) of
the Positive and Negative Syndrome Scale (PANSS) would be better represented
by expressive and experiential deficit factors, rather than by a single factor model,
using confirmatory factor analysis (CFA). Two hundred and twenty individuals with
schizophrenia spectrum disorders completed the PANSS; subsamples additionally
completed the Brief Negative Symptom Scale (BNSS) and the Motivation and Pleasure
Scale—Self-Report (MAP-SR). CFA results indicated that the two-factor model fit the
data better than the one-factor model; however, latent variables were closely correlated.
The two-factor model’s fit was significantly improved by accounting for correlated
residuals between N2 (emotional withdrawal) and N6 (lack of spontaneity and flow
of conversation), and between N4 (passive social withdrawal) and G16 (active social
avoidance), possibly reflecting common method variance. The two NSF factors exhibited
differential patterns of correlation with subdomains of the BNSS and MAP-SR. These
results suggest that the PANSS NSF would be better represented by a two-factor model
than by a single-factor one, and support the two-factor model’s adequate criterion-
related validity. Common method variance among several items may be a potential
source of measurement error under a two-factor model of the PANSS NSF.
Keywords: schizophrenia, psychosis, negative symptoms, subdomain, expressive deficits, experiential deficit
INTRODUCTION
Negative symptoms are an important dimension of schizophrenia symptoms, and are independent
of positive and disorganized symptoms; negative symptoms have under-known pathological
mechanisms and few treatment options (Harvey et al., 2006; Marder et al., 2011). To advance
knowledge of negative symptoms’ potential pathology and means of intervention, valid and
reliable measurement of negative symptoms is mandatory. Measurement requires assessment
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tools that accurately reflect the symptoms’ conceptualization.
Recently, a consensus has emerged on the existence of multiple
dimensions of negative symptoms (Blanchard and Cohen,
2006). Specifically, avolition (lack of interest in daily activities),
asociality (reduced social interest and social withdrawal), and
anhedonia (reduced ability to experience or anticipate pleasure)
comprise the experiential deficits of negative symptoms, which
may be correlated with, but are distinct from, expressive deficits
such as blunted affect (diminished facial expression) and alogia
(poverty of speech; Kirkpatrick et al., 2006). This two-factor
structure has been verified in the course of the development
of new assessments of negative symptoms and is reflected in
the renewed conceptualization of negative symptoms in the
Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (Messinger et al., 2011; Strauss et al., 2012; Kring et al.,
2013).
The proposition that negative symptoms are composed of
more than a single dimension has important implications:
different dimensions might possess different underlying causes,
courses, or treatment responses. Consistent with this idea, recent
research suggests that the two dimensions mentioned above may
have distinct clinical and functional correlates (Galderisi et al.,
2013; Lyne et al., 2014; Quinlan et al., 2014). For example,
Galderisi et al.’s (2013) 5-year longitudinal study found that
“avolition” and “poor emotional expression” each predicted
different aspects of social functioning outcomes: the former
predicted social contact; the latter predicted household activities.
Similarly, Ergül and Üçok (2015) found that “expressive” and
“motivation/pleasure” deficits had distinct clinical correlates;
for instance, the former was associated with earlier onset,
lower education, and poorer performance in cognitive tests,
and the latter with duration of untreated psychosis and
family history of psychosis. Additionally, Cella et al. (2014)
reported that detailed symptom dimensions can be used to
increase the sensitivity of treatment response evaluations. This
suggests that separate assessment of two dimensions would
provide such benefits as more sensitive treatment-outcome
measures and increased opportunity to investigate the distinct
pathophysiology underlying the potentially separable negative
symptom dimensions.
The Positive and Negative Syndrome Scale (PANSS) is widely
used to measure psychiatric symptoms and provides valid and
useful information about negative symptoms (Kirkpatrick et al.,
2006). Recent research has reported that the PANSS negative
symptoms factor (NSF) has greater content validity than the
original negative symptoms scale, and is reliable, valid, and
sensitive to treatment responses (Kirkpatrick et al., 2006; Edgar
et al., 2014). Few studies have examined if the NSF has a
similar two-factor structure to second-generation instruments for
negative symptoms such as the Clinical Assessment Interview for
Negative Symptoms (CAINS) and the Brief Negative Symptom
Scale (BNSS). Among earlier measures, the two-factor structure
was identified in the Scale for the Assessment of Negative
Symptoms (Kelley et al., 1999) and Schedule for Deficit Syndrome
(Galderisi et al., 2013). Notably, one recent study proposed a two-
factor structure within the NSF using exploratory factor analysis
(EFA; Fervaha et al., 2014). It is therefore timely to determine
if the PANSS NSF is best represented by a two- or single-factor
structure, and examine its external validity with novel negative
symptoms scales.
We aimed to examine the factor structure of the NSF in
Korean individuals with chronic schizophrenia by comparing
the fitness of the two-factor and single-factor models. We
also aimed to establish the two-factor model’s external validity
by investigating its agreement with the BNSS and MAP-SR.
Demographic, clinical, and neurocognitive correlates of the two
factors were examined.
MATERIALS AND METHODS
Participants
Our sample included 220 patients (194 outpatients, 26
inpatients; 128 males, 92 females) diagnosed with schizophrenia,
schizoaffective disorder, or psychotic disorder not otherwise
specified according to the Diagnostic and Statistical Manual
of Mental Disorders-IV. The primary diagnosis was
confirmed using the Korean version of the Mini-International
Neuropsychiatric Interview-Plus for outpatients and the
Structured Clinical Interview for DSM-IV Axis I Disorders for
inpatients (Lecrubier et al., 1997; First et al., 2012). Participants
were recruited from community mental health centers and an
inpatient psychiatric hospital. All participants but one were
stably on antipsychotic medications. Participants were excluded
if they met criteria for brain injuries, developmental disorders,
histories of substance abuse, or neurological disorders. Written
informed consent was obtained before participation. This study
was approved by the local institute review board of Korea
University.
Procedure
Data were collected in the context of several research projects,
including a validation trial of the BNSS, efficacy trials of
psychosocial rehabilitation programs, and experimental studies
on negative symptoms. Participants were administered the
PANSS at the start of the study by five raters (four master’s-
level and one doctoral-level in clinical psychology) who had been
trained using the PANSS’ educational materials and whose inter-
rater reliability had been established (α = 0.76). A subsample
of participants was additionally administered the MAP-SR
(n = 141) and BNSS (n = 78) by three raters (two master’s-level
and one doctoral-level in clinical psychology). These raters were
trained using the original BNSS manual; inter-rater reliability was
α= 0.83.
Measures
Positive and Negative Symptom Scale (PANSS)
The PANSS measures comprehensive psychiatric symptoms,
including positive, negative, and general symptoms (Kay et al.,
1987). The PANSS includes 30 items; responses used a 7-point
Likert scale and were given in semi-structured interviews. Yi
et al. (2001) reported that the internal consistency of the Korean
version of the PANSS is α = 0.73, α = 0.84, and α = 0.74
for the positive, negative, and general psychopathology scales,
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respectively. In the current study, the Cronbach’s alpha of the NSF
(seven items: N1, N2, N3, N4, N6, G7, and G16) was 0.90; the
inter-rater reliability of our trained raters was 0.76.
Motivation and Pleasure Scale—Self Report
(MAP-SR)
The MAP-SR was used to measure the experiential deficits of
negative symptoms such as anhedonia and amotivation (Llerena
et al., 2013). This is a self-report measure including 15 items
and developed based on the CAINS. Lower scores indicate
low pleasure and motivation in social, work, and recreational
domains. It measures diverse aspects of hedonic and motivational
experiences including retrospective and anticipatory pleasure,
and motivation and efforts to engage in such activities. The
Cronbach’s alpha of the MAP-SR in this study was 0.92.
Brief Negative Symptom Scale (BNSS)
The BNSS is a newly developed semi-structured clinical interview
assessment that measures the severity of negative symptoms in
schizophrenia and schizoaffective disorder (Strauss et al., 2012).
The BNSS is comprised of six subscales: anhedonia, asociality,
avolition, blunted affect, alogia, and lack of general distress. There
are 13 items in total, which are rated on a 7-point scale ranging
from the absence of symptoms (0) to extremely severe symptoms
(6). Symptoms are rated in terms of severity in the past week.
Previous studies have found a two-factor structure: expressive
deficits, comprised of the blunted affect and alogia subscales, and
experiential deficits, comprised of the anhedonia, asociality, and
avolition subscales. It has exhibited good internal consistency
(α = 0.94) and discriminant and convergent validity (Strauss
et al., 2012). In this study, the Korean version of the BNSS showed
good internal consistency (α= 0.94) and the two-factor structure
(expressive and experiential deficits factors, correlation: α= 0.80)
of the original study exhibited adequate data fit: χ2 = 77.41,
df = 49 (p < 0.01), NC = 1.58, CFI = 0.96, TLI = 0.95,
RMSEA= 0.086 [CI: 0.047–0.121, 90%], and SRMR= 0.056.
Trail Making Test Parts A and B (TMT-A/B)
The TMT-A/B was included to examine basic cognitive function’s
relationship with two dimensions of negative symptoms. In
part A of the Trail Making Test (TMT-A), subjects connected
scattered numerals ranging from 1 to 25 in numerical order.
This part measured psychomotor speed and attention. In part
B (TMT-B), subjects connected 15 numerals and 14 letters
alternately in ascending order. This part measured executive
functions (e.g., mental flexibility), which are related to frontal
lobe functioning (Reitan, 1958). Time taken to complete each task
was used in the analysis.
Analysis
Confirmatory Factor Analysis (CFA)
Confirmatory factor analysis was conducted using a two-factor
model identified in EFA in the past study (Fervaha et al.,
2014). We chose to use CFA instead of EFA because we
already had a theoretical framework, an existing model proposed
through empirical research, and an alternative model to compare.
Specifically, seven NSF items (N1, blunted affect; N2, emotional
withdrawal; N3, poor rapport; N4, passive social withdrawal;
N6, lack of spontaneity and flow of conversation; G7, motor
retardation; G16, active social avoidance) were employed as
observed variables. The fitness of the model in which the
expressive deficit factor was represented by N1, N2, N3, N6,
and G7 and experiential deficit factor represented by N2, N4,
and G16 was subsequently computed and evaluated. The fit of
the model was also compared with that of one-factor model, in
which the seven NSF items were loaded onto one underlying
factor. The maximum likelihood method was used for estimation
as the data did not show any great tendency to non-normality
(skewness < 2.00, Kurtosis < 7.00; West et al., 1995). Values
of multiple indices of goodness-of-fit were computed and used
for model evaluation: chi-square, comparative fit index (CFI
values of >0.90 are indicative of acceptable fit), Tucker–Lewis
index (TLI > 0.90), root mean square error of approximation
(RMSEA < 0.10), and standardized root mean square residual
(SRMR < 0.08; MacCallum et al., 1996; Hu and Bentler, 1999).
As the value of chi-square is greatly affected by sample size, the
normed chi-square (NC) was also calculated by dividing the chi-
square value by the corresponding degrees of freedom (Bagozzi
and Yi, 1988). An NC of less than 5.00 is considered good
(Schumacker and Lomax, 2004). The models were also compared
using chi-square difference tests (Bollen, 2014). CFA and chi-
square difference tests were conducted using Mplus 6.1 and the
lavaan package implemented in R x64 3.1.0 (Rosseel, 2012).
Correlational Analysis
Pearson correlation coefficients were calculated between the two
factors (composite score) of the NSF and demographic variables.
Demographic variables included age, gender, years of education,
age of onset, and illness duration. Regarding gender, point-
biserial correlations were calculated using dummy variables
(0 = male, 1 = female). The external validity of the two NSF
factors was assessed by analyzing these two factors’ specific
relationship with expressive and experiential deficits in other
measures of negative symptoms, and with cognitive function.
Specifically, the two NSF factors’ correlation with the MAP-
SR, the two subdomains of the BNSS, and the TMT-A/B was
calculated using Pearson’s r. Williams’ test (implemented in R x64
3.1.0) was used to test the significance of differences in correlation
coefficients’ magnitude (Steiger, 1980).
RESULTS
Demographic and Clinical Information
Demographic data indicated that our sample was mostly
composed of patients with a primary diagnosis of schizophrenia.
Most participants were chronic patients with a mean illness
duration of 15.85 ± 9.57 years and generally mild symptoms.
All participants except one were taking antipsychotics. Full
demographic characteristics are presented in Table 1. The MAP-
SR and BNSS were additionally administered to subsamples
(n= 141; n= 78, respectively). No significant differences existed
regarding age, gender, education, or PANSS symptoms between
subsamples and the full sample (p> 0.05).
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TABLE 1 | Demographic and clinical information.
Participants (n = 220)
Primary diagnosis Schizophrenia 201
Schizoaffective 9
Psychotic disorder NOS 10
Age Mean (SD) 41.20 (10.47)
Gender (male) % 58.20
Years of education1 Mean (SD) 12.45 (2.54)
Age of onset2 Mean (SD) 24.01 (8.14)
Duration of illness2 Mean (SD) 16.56 (9.80)
Antipsychotics Medicated 219
Non-medicated 1
PANSS positive3 Mean (SD) 2.59 (1.01)
PANSS negative Mean (SD) 2.63 (1.01)
PANSS disorganization Mean (SD) 2.28 (0.89)
PANSS excitation Mean (SD) 1.91 (0.80)
PANSS depression Mean (SD) 2.19 (0.92)
PANSS, Positive and Negative Syndrome Scale; NOS, not otherwise specified.
1Two hundred and twelve participants reported years of education. 2One hundred
and ninety-six participants reported age of onset and illness duration. 3Mean scores
on the five PANSS factors were reported by 218 participants due to missing values
(Lancon et al., 2000).
Confirmatory Factor Analysis
The one-factor model yielded the following fit index values:
χ2 = 114.600, df = 14 (p < 0.001), NC = 8.186, CFI = 0.893,
TLI = 0.839, RMSEA = 0.181 [CI: 0.151–0.212, 90%], and
SRMR = 0.053, indicating poor fit. In contrast, the two-
factor model exhibited substantially better data fit, except
regarding its RMSEA value, which remained high: χ2 = 60.356,
df = 13 (p < 0.001), NC = 4.643, CFI = 0.950, TLI = 0.919,
RMSEA = 0.129 [CI: 0.097–0.162, 90%], and SRMR = 0.037.
It should be noted that the two latent factors were closely
correlated, r = 0.854. A third model was added with two
correlated residuals between N2 (emotional withdrawal) and N6
(lack of spontaneity and flow of conversation) and between N4
(passive social withdrawal) and N16 (active social avoidance),
as indicated by the modification indices (Figure 1). This
third model exhibited the most satisfactory fit of the three:
χ2 = 28.887, df = 11 (p < 0.01), NC = 2.626, CFI = 0.981,
TLI = 0.964, RMSEA = 0.086 [CI: 0.048–0.125, 90%], and
SRMR = 0.026. Chi-square difference tests comparing the three
models found that the two-factor model with no correlated
residuals exhibited significantly better fit than the one-factor
model (χ2 = 54.244, df = 1, p < 0.001), and that the two-
factor model with correlated residuals exhibited significantly
better fit than the two-factor model with no correlated residuals,
χ2 = 31.469, df = 2, p < 0.001. Standardized factor loadings
of the observed variables (>0.40) indicated that latent factors in
the third model were represented well by the observed variables;
therefore, the third model was selected as the final model
(Table 2).
Correlation Analysis
The two NSF factors (expressive and experiential deficit)
identified in the CFA exhibited non-significant correlations
with age, gender, age of onset, illness duration, and years of
education. Additionally, the experiential deficit factor of the NSF
was significantly negatively correlated with total MAP-SR scores
(r = −0.432, p < 0.001) and positively with BNSS expressive
and experiential deficit scores (r = 0.560, p < 0.001; r = 0.706,
p < 0.001, respectively; Table 3). The expressive deficit factor of
the NSF was significantly negatively correlated with total MAP-
SR scores (r = −0.248, p < 0.01) and positively with BNSS
expressive and experiential deficit scores (r = 0.670, p < 0.001;
r = 0.592, p < 0.001, respectively). We subsequently examined
whether the two NSF factors exhibited specific relationships
with subdomains of the BNSS and MAP-SR. The difference
in correlation between the expressive deficits factor and the
two factors (expressive and experiential deficits) of the BNSS
was significant, t(217) = 2.19, p < 0.05. The difference in
correlation between the experiential deficit factor of the NSF and
the two factors of the BNSS was also significant, t(217) = −4.22,
p < 0.001. Further, the difference in correlation between the
two NSF factors and total MAP-SR scores was also significant,
t(217) = 4.00, p < 0.001. Finally, the expressive deficits factor
but not the social amotivation factor was correlated with poorer
performance on the TMT-B (r = 0.214, p< 0.001).
Post hoc Subgroup Analysis
To further explore the existence of clinical heterogeneity in
groups with distinct profiles of negative symptoms dimensions,
we identified two patient groups who had either relatively
high (>3) expressive but low (≤3) experiential symptoms
(n = 17, 7.727%) or low expressive but high experiential
symptoms (n = 36, 16.364%) according to their NSF scores.
We then compared the demographic and clinical characteristics
of these two groups. The former group exhibited more
severe mean overall negative symptoms than the latter group,
t(50.833) = −2.389, p < 0.05. When controlling for overall
negative symptom severity, the former group exhibited higher
MAP-SR scores, F(1,30) = 13.638, p = 0.001, lower PANSS
emotional symptoms, F(1,47) = 5.185, p < 0.05, and higher
probability to smoke, p< 0.05.
DISCUSSION
This study examined the factor structure of the PANSS NSF in
Korean individuals with chronic schizophrenia. It also provides
novel information regarding the discriminant and convergent
validity of sub-factors of the PANSS NSF with newly developed
negative symptoms measurements (i.e., the BNSS and MAP-SR)
and neurocognitive tasks.
The two-factor structure of the NSF exhibited significantly
better data fit than the single-factor model, indicating that
clinicians and researches may obtain more information on
negative symptoms by using the two-factor structure. The two-
factor model also exhibited adequate convergent and divergent
validity with second-generation measures of negative symptoms.
That is, although both NSF factors were correlated with the
two subdomains of the BNSS (r > 0.05), the experiential NSF
factor exhibited closer correlation with the experiential BNSS
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FIGURE 1 | Three models of the negative symptoms factor (NSF). (1) One-factor model; (2) Two-factor model with no correlated residuals; (3) Two-factor
model with correlated residuals. The circles at the top indicate latent factors; the boxes at the bottom indicate PANSS items connected to their corresponding
factors. The arrows connecting boxes at the bottom indicate correlated residuals. For simplicity, the error terms of the PANSS items are not shown in this figure.
TABLE 2 | Standardized factor loadings in the third model.
PANSS
NSF-expressive
PANSS
NSF-experiential
N1 Flat affect 0.85 –
N3 Poor rapport 0.81 –
N6 Lack of spontaneity and
flow of conversation
0.83 –
G7 Motor retardation 0.58 –
N2 Emotional withdrawal – 0.94
N4 Passive social withdrawal – 0.82
G16 Active social avoidance – 0.60
PANSS NSF-expressive, the expressive factor of the negative symptom factor in the
PANSS; PANSS NSF-experiential, the experiential factor of the negative symptom
factor in the PANSS.
factor than with the expressive BNSS factor. Conversely, the
expressive NSF factor was significantly more closely correlated
with the expressive BNSS factor than with the experiential BNSS
factor. Finally, MAP-SR scores were more closely correlated
with the experiential NSF factor than with the expressive NSF
factor.
The two-factor model’s fit was significantly improved
when it was adopted with correlated residuals between N2
(emotional withdrawal) and N6 (lack of spontaneity and flow
of conversation), and between N4 (passive social withdrawal)
and G16 (active social avoidance). These correlated errors may
reflect a common method effect, since item N2 and N6 share a
rating method (i.e., behavioral observations during interviews).
This would mean that low spontaneity and poverty of speech in
the interviewee (N6) were sources of high scores on emotional
withdrawal (N2). Item N4 and G16 also share a rating method
(i.e., reports from families and staff) in addition to their shared
content. This may lead to slight overestimation of the reliability
of the experiential NSF factor, as clinicians and researchers
are likely to use summed scores of items belonging to each
factor, which do not account for correlated errors among
items.
Regarding neurocognitive correlates of negative symptoms,
we observed that longer completion time in TMT-B but not
in the TMT-A was correlated with high expressive NSF factor
scores. This finding may corroborate Cohen et al. (2013),
who found that expressive deficits were related to performance
on the Coding test but not to simple attentional ability as
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TABLE 3 | External validity with second-generation measures of negative
symptoms.
PANSS
NSF-expressive
composite score
PANSS
NSF-experiential
composite score
MAP-SR total −0.248∗∗ −0.432∗∗∗
BNSS-expressive 0.670∗∗∗ 0.560∗∗∗
BNSS-experiential 0.592∗∗∗ 0.706∗∗∗
PANSS NSF-expressive composite 1 0.716∗∗∗
PANSS NSF-experiential composite 0.716∗∗∗ 1
Cronbach’s alpha 0.847 0.860
MAP-SR, Motivation and Pleasure Scale—-Self report; BNSS-expressive, the
expressive factor of the Brief Negative Symptom Scale. MAP-SR (n = 141), BNSS
(n = 78). ∗∗p < 0.01, ∗∗∗p < 0.001.
measured by the forward digit-span test in schizophrenia.
This indicates that expressive deficits may be associated with
impairments in cognitive functions such as cognitive flexibility
and psychomotor abilities, which the TMT-B and Coding
test both assess, possibly supporting the cognitive resource
limitation model of diminished expressivity (Cohen et al., 2012).
That model proposes that restricted expression in individuals
with schizophrenia liability largely reflects depleted cognitive
resources.
It should be noted, however, that the present study found close
correlation between the two latent variables (i.e., the expressive
and experiential factors) within the NSF. This suggests that
the two dimensions measured by the NSF largely overlap with
each other and may partly reflect a non-independent (though
potentially dissociable) relationship between these dimensions,
consistent with the current understanding of this symptom
cluster (Blanchard and Cohen, 2006). Past studies have found
that the two observed factors are correlated with a r-value of
around 0.55 in the CAINS (Valiente-Gómez et al., 2015), 0.47
in the SANS (Mueser et al., 1994), and 0.65 in the PANSS
(Fervaha et al., 2014). In addition to shared assumed variance
between its two factors, the PANSS NSF may have a less
differentiated factor structure due to its less extensive set of items,
which cover a narrower range of negative symptom domains
compared with instruments such as the SANS, CAINS, and
BNSS (Daniel, 2013). Reliance on observable behavior during
interviews when rating experiential deficits (e.g., N2, emotional
withdrawal) may also contribute to this somewhat blurred
structure, as indicated by the correlation of errors between N2
and N6.
Nonetheless, considering the results of the model comparison,
the two-factor model seems to better represent the NSF
than the conventional single-factor model, especially regarding
sources of systematic error. It also seems to measure separable
negative symptom dimensions to some degree, given the two
NSF sub-factors’ different relationships with other negative
symptom scales and cognitive tasks. This is in line with the
growing consensus on the multi-dimensionality of negative
symptoms. Researchers have long observed that negative
symptoms have different aspects, e.g., the “weakening of the
wellsprings of volition” and “restricted affect” (Bleuler, 1950;
Kraepelin, 1971). It has also been noted that expressive deficits,
or diminished facial, vocal, and bodily expressions, do not
always accompany impoverished internal experience (Kring
and Moran, 2008). Recent research has therefore examined
the mechanisms of specific dimensions of negative symptoms
such as blunted facial affect, poverty of speech, lack of
anticipatory pleasure, and amotivation, rather than a single
broad concept of negative symptoms (Strauss et al., 2013;
Rocca et al., 2014; Hartmann et al., 2015; Kirschner et al.,
2015).
The multi-factor solution has important clinical implications:
it is able to acknowledge potential clinical heterogeneity among
groups with differing profiles of specific symptom dimensions.
For example, a significant portion of participants in the current
sample was found to belong to either a high expressive/low
experiential deficits (7.73%) or low expressive/high experiential
deficits group (16.36%). These two groups were found to
differ in psychiatric symptoms and proportion of smokers
in our post hoc analysis. It has been reported that sub-
dimensions of negative symptoms may have unique associations
with functional outcomes, family history, illness course,
and cognitive function. For instance, cross-sectional and
longitudinal studies have found functional impairments to be
more closely correlated with the experiential deficit domain
than with the expressive deficit domain (Strauss et al., 2013;
Ergül and Üçok, 2015), although Gur et al. (2006) reported
close correlations with expressive deficits. Under the unitary
concept of negative symptoms, valuable information on
the etiology, mechanism, course, and treatment response
of distinct negative symptoms may be lost (Rocca et al.,
2014).
The present study has some limitations: It examined
chronic patients with mild levels of psychiatric symptoms
and who were taking antipsychotic medications. Therefore,
this study’s results are not generalizable to patients who
are unmedicated in different illness courses such as high
clinical risk or first episode stage, or who have more severe
symptomatology. Additionally, only two neurocognitive tasks
were used in this study; future research should use comprehensive
neurocognitive and social cognitive assessments to examine
distinct cognitive correlates of the two negative symptom
factors.
In sum, the current study indicates that the latent structure
of the PANSS NSF is better represented by the two-factor
model than by the one-factor model. Additionally, the
two NSF factors exhibited adequate external validity in
comparison with second-generation symptom measures.
Measurement under the two-factor model of the NSF
would be much improved if measurement errors possibly
resulting from method variance were addressed. The
current study provides a practical way to incorporate
sub-dimensions of negative symptoms in clinical practice
and research using the PANSS. Future research should
further examine the sensitivity of this two-factor solution
in predicting illness course, functioning, and treatment
response associated with potentially discrete negative symptom
dimensions.
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